Real-World Treatment Patterns and Adherence to Oral Medication Among Patients with Bipolar Disorders: A Retrospective, Observational Study Using a Healthcare Claims Database

References

• Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995;152(11):1635–1640.7485627
   PubMed Web of Science ®Google Scholar
• Simhandl C, König B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry. 2014;75(3):254–263. doi:10.4088/JCP.13m0860124717379
   PubMed Web of Science ®Google Scholar
• Müller-Oerlinghausen B, Berghöfer A, Bauer M. Bipolar disorder. Lancet. 2002;359(9302):241–247. doi:10.1016/S0140-6736(02)07450-011812578
   PubMed Web of Science ®Google Scholar
• Carvalho AF, Dimellis D, Gonda X, Vieta E, McLntyre RS, Fountoulakis KN. Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry. 2014;75(6):e578–586. doi:10.4088/JCP.13r0890525004199
   PubMed Web of Science ®Google Scholar
• Hong J, Reed C, Novick D, Haro JM, Windmeijer F, Knapp M. The cost of relapse for patients with a manic/mixed episode of bipolar disorder in the EMBLEM study. Pharmacoeconomics. 2010;28(7):555–566. doi:10.2165/11535200-000000000-0000020405969
   PubMed Web of Science ®Google Scholar
• García S, Martínez-Cengotitabengoa M, López-Zurbano S, et al. Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review. J Clin Psychopharmacol. 2016;36(4):355–371. doi:10.1097/JCP.000000000000052327307187
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/21704726539470
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Hyakuta TA. Japanese literature review of medication adherence assessments. Jpn Red Cross Hiroshima Coll Nurs. 2016;16:57–65. [in Japanese].
   Google Scholar
• Bohlken J, Konrad M, Kostev K. Adherence to neuroleptic treatment in psychiatric practices: a retrospective study of 55 practices with more than 5000 bipolar and schizophrenic patients in Germany. Psychiatry Res. 2020;284:112758. doi:10.1016/j.psychres.2020.11275831955056
   PubMed Web of Science ®Google Scholar
• Greene M, Yan T, Chang E, Hartry A, Touya M, Broder MS. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder. J Med Econ. 2018;21(2):127–134. doi:10.1080/13696998.2017.137941228895758
   PubMed Web of Science ®Google Scholar
• Yan T, Greene M, Chang E, Hartry A, Touya M, Broder MS. Medication adherence and discontinuation of aripiprazole once-monthly 400 mg (AOM 400) versus oral antipsychotics in patients with schizophrenia or bipolar i disorder: a real-world study using US claims data. Adv Ther. 2018;35(10):1612–1625. doi:10.1007/s12325-018-0785-y30206822
   PubMed Web of Science ®Google Scholar
• Leclerc E, Mansur RB, Brietzke E. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J Affect Disord. 2013;149(1–3):247–252. doi:10.1016/j.jad.2013.01.03623489403
   PubMed Web of Science ®Google Scholar
• Chakrabarti S. Treatment-adherence in bipolar disorder: a patient-centred approach. World J Psychiatry. 2016;6(4):399–409. doi:10.5498/wjp.v6.i4.39928078204
   PubMed Web of Science ®Google Scholar
• Colom F, Vieta E, Tacchi MJ, Sánchez-Moreno J, Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord. 2005;7(Suppl 5):24–31. doi:10.1111/j.1399-5618.2005.00248.x16225557
   PubMed Web of Science ®Google Scholar
• Velligan DI, Weiden PJ, Sajatovic M, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(Suppl 4):1–46. doi:10.4088/JCP.7090su1cj19686636
   PubMed Web of Science ®Google Scholar
• Corréard N, Consoloni JL, Raust A, et al. Neuropsychological functioning, age, and medication adherence in bipolar disorder. PLoS One. 2017;12(9):e0184313. doi:10.1371/journal.pone.018431328873468
   PubMed Web of Science ®Google Scholar
• Bauer M, Glenn T, Alda M, et al. Trajectories of adherence to mood stabilizers in patients with bipolar disorder. Int J Bipolar Disord. 2019;7(1):19. doi:10.1186/s40345-019-0154-z31482209
   PubMed Web of Science ®Google Scholar
• Japanese Society of Mood Disorders. Treatment guidelines review committee for mood disorders: I. bipolar disorder 2020; 2020. Available from: https://www.secretariat.ne.jp/jsmd/iinkai/katsudou/data/guideline_sokyoku2020.pdf. Accessed 1218, 2020. [in Japanese].
   Google Scholar
• JMDC Inc. Tokyo. JMDC claims database; 2019. Available from: https://www.jmdc.co.jp/en/jmdc-claims-database. Accessed 1218, 2020. [in Japanese].
   Google Scholar
• Japanese Society for Pharmacoepidemiology. Survey of Japanese databases in Japan available for clinical/pharmaco-epidemiology; 2019. Available from: http://www.jspe.jp/mt-static/FileUpload/files/JSPE_DB_TF_E.pdf. Accessed 1218, 2020.
   Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.8316224307
   PubMed Web of Science ®Google Scholar
• Nau DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence; 2012. Available from: http://ep.yimg.com/ty/cdn/epill/pdcmpr.pdf. Accessed 1218, 2020.
   Google Scholar
• ABILIFY®(aripiprazole) [package insert]. Tokyo; Otsuka; 2020. Available from: https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/180078_1179045F4022_1_19. Accessed 920, 2000. [in Japanese].
   Google Scholar
• Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003;60(3):261–269. doi:10.1001/archpsyc.60.3.26112622659
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530–537. doi:10.1001/archpsyc.59.6.53012044195
   PubMed Web of Science ®Google Scholar
• Tsuboi T, Suzuki T, Azekawa T, et al. Factors associated with non-remission in bipolar disorder: the multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics (MUSUBI). Neuropsychiatr Dis Treat. 2020;16:881–890. doi:10.2147/NDT.S24613632280229
   PubMed Web of Science ®Google Scholar
• Bipresso®(quetiapine) [prescribing information]; 2020. Available from: https://pins.japic.or.jp/pdf/newPINS/00066992.pdf. Accessed 929, 2020. [in Japanese].
   Google Scholar
• Vella T, Mifsud J. Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring. J Pharm Pharmacol. 2014;66(6):747–759. doi:10.1111/jphp.1220924392714
   PubMed Web of Science ®Google Scholar
• Vega P, Barbeito S, de Azúa SR. Bipolar disorder differences between genders: special considerations for women. Womens Health (Lond). 2011;7(6):663–674. doi:10.2217/WHE.11.7122040208
   PubMedGoogle Scholar
• McIntyre RS. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey. J Clin Psychiatry. 2009;70(Suppl 3):5–11. doi:10.4088/JCP.7075su1c.0219570496
   PubMed Web of Science ®Google Scholar
• Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry. 2002;47(5):426–436. doi:10.1177/07067437020470050312085677
   PubMed Web of Science ®Google Scholar
• Iwata N, Inagaki A, Sano H, Niidome K, Kojima Y, Yamada S. Treatment persistence between long-acting injectable versus orally administered aripiprazole among patients with schizophrenia in a real-world clinical setting in Japan. Adv Ther. 2020;37(7):3324–3336. doi:10.1007/s12325-020-01396-w32500455
   PubMed Web of Science ®Google Scholar
• Statistics of Japan. Estimated population in February 2019; 2019. Available from: https://www.stat.go.jp/data/jinsui/pdf/201902.pdf. Accessed 713, 2020. [in Japanese].
   Google Scholar